IP Theft at Line Rate — Your Drug Pipeline in Enemy Hands
Pharmaceutical R&D networks, GMP manufacturing, and cold chain distribution represent $2.4 trillion in IP. P4S SOFTLESS FPGA enforces data sovereignty at network level — zero exfiltration vectors.
Pharmaceuticals OT Network Live Attack + Encryption Race
Pharma OT — SCADA, PLC-4, HMI & OT GW secured at 1 Gbps IPSec each. P4S SF-106-8 enforces absolute R&D/manufacturing/clinical segmentation — GMP batch record exfiltration and process manipulation blocked in under 3 microseconds.
The documented attack playbook used against pharmaceuticals infrastructure — and why a legacy software firewall fails at every stage.
T+0:00
⚠
Research network spear-phish
Nation-state actor targets lead oncology researcher. Credential harvested. Software firewall passes authenticated session — legitimate access patterns.
T+0:03
⚠
Clinical trial database accessed
Phase III clinical trial database accessed — 18,000 patient records and proprietary compound formulations. Software firewall: authenticated user, no alert.
T+0:09
⚠
150GB IP exfiltrated
Clinical trial data, compound synthesis routes, and manufacturing batch records exfiltrated via HTTPS. Software DLP disabled — too many false positives.
T+0:00 — P4S
✓
Data boundaries enforced in hardware
FPGA per-port segmentation — authenticated user session cannot cross research/manufacturing boundary. IP stays contained.
Hardware vs Software
Why Software Firewalls Fail
⚠ LEGACY SOFTWARE FIREWALL
✗Pharmaceutical IP exfiltration via HTTPS invisible to software firewalls without SSL inspection — which creates its own HIPAA issues
✗GMP manufacturing (DeltaV, SCADA) uses proprietary protocols not supported by software firewall DPI
✗Software DLP high false positive rates on research data transfers — teams disable it, eliminating protection
✗FDA 21 CFR Part 11 requires audit trail integrity — software logs can be modified by OS-level attacker
✓Hardware audit logs for FDA 21 CFR Part 11 compliance — immutable, timestamped, and isolated from software attack
✓AES-256-GCM-16 IPSec encrypts all inter-segment transfers — network-level IP exfiltration impossible
✓TAP-106-8 provides 100% research network capture for IP forensics — zero impact on data transfer performance
Theme C — The Breakthrough
P4S SOFTLESS™ Hardware Solves All Three Problems in Silicon
P4S completely replaces software stacks with hardcoded FPGA logic. No Linux. No Windows. No memory stack. No OS exploit path. No 1 Gbps performance ceiling. No quantum-vulnerable cipher implementation.
Zero Software Flaws
No Linux or Windows OS means zero memory stack overflows, zero remote OS exploits, and zero CVE exposure. The attack surface is physically absent — not patched, not mitigated. Absent.
FPGA logic hardwired at manufacture
CORE TECHNOLOGY
Line-Rate at Any Load
FPGA logic processes 18 Gbps total (SF-106-8) at wire speed regardless of attack volume. At 1 Gbps DDoS load, CPU consumption is zero. Legitimate OT packets are never dropped. PLC-4 polling never times out.
<3μs
64B frame IPSec
1 Gbps
IPSec per port
18 Gbps
Total SF-106-8
9×
Independent FW
Quantum-Resistant Encryption
AES-256-GCM-16 implemented in FPGA silicon — not in software. The only symmetric cipher that survives Grover's algorithm reduction. Your pharmaceuticals OT traffic stays encrypted even as quantum capabilities advance.
AES-256-GCM-16 · IPSec · FIPS 140-3
SF-106 Series Architecture — Pharmaceuticals Deployment